0001566373-15-000002.txt : 20150227 0001566373-15-000002.hdr.sgml : 20150227 20150227140117 ACCESSION NUMBER: 0001566373-15-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150227 DATE AS OF CHANGE: 20150227 EFFECTIVENESS DATE: 20150227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-232149 FILM NUMBER: 15657028 BUSINESS ADDRESS: STREET 1: 113 CEDAR STREET STREET 2: SUITE 7 CITY: MILFORD STATE: MA ZIP: 01757 BUSINESS PHONE: 508-473-5993 MAIL ADDRESS: STREET 1: 113 CEDAR STREET STREET 2: SUITE 7 CITY: MILFORD STATE: MA ZIP: 01757 D/A 1 primary_doc.xml X0707 D/A LIVE 0001566373 Spring Bank Pharmaceuticals, Inc. 113 CEDAR STREET SUITE 7 MILFORD MA MASSACHUSETTS 01757 508-473-5993 DELAWARE None None Corporation true Douglas John Jensen 113 Cedar Street Suite 7 Milford MA MASSACHUSETTS 01757 Executive Officer Director Radhakrishnan Parameswaran Iyer 113 Cedar Street Suite 7 Milford MA MASSACHUSETTS 01757 Executive Officer Director Guy Macdonald 113 Cedar Street Suite 7 Milford MA MASSACHUSETTS 01757 Director Jonathan Ellsworth Bates 113 Cedar Street Suite 7 Milford MA MASSACHUSETTS 01757 Director David Arkowitz 113 Cedar Street Suite 7 Milford MA MASSACHUSETTS 01757 Director Biotechnology Decline to Disclose 06b true 0001566373-15-000001 2014-12-31 false true false 0 Gilford Securities 8076 None None 777 Third Avenue 17th Floor New York NY NEW YORK 10017 All States false 21647967 21647967 0 false 72 1589317 0 0 true false Spring Bank Pharmaceuticals, Inc. /s/ Douglas J. Jensen Douglas J. Jensen Chief Executive Officer 2015-02-26